Clinical trial
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in…
NCT00332488 · Mannkind Corporation, Industry · Completed
Key facts
| NCT number | NCT00332488 |
|---|---|
| Title | Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes |
| Official title | A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With… |
| Lead sponsor | Mannkind Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Technosphere Insulin, Metformin & Secretagogues, Technosphere Insulin & Metformin |
| Enrollment | 547 |
| Start date | Dec 1, 2004 |
| Primary completion | Mar 1, 2008 |
| First posted | Jun 1, 2006 |
| Last update posted | Oct 16, 2014 |
| Countries | Argentina, Brazil, Canada, Chile, Czechia, Mexico, Poland, Russia, Spain, Ukraine, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: